Pharmacology of anticancer drugs in the elderly populationWILDIERS, Hans; HIGHIEY, Martin S; DE BRUIJN, Ernst A et al.Clinical pharmacokinetics. 2003, Vol 42, Num 14, pp 1213-1242, issn 0312-5963, 30 p.Article

Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancerMAES, Toon; WILDIERS, Hans; HEYE, Sam et al.Breast cancer research and treatment. 2008, Vol 110, Num 1, pp 135-142, issn 0167-6806, 8 p.Article

Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor modelWILDIERS, Hans; AHMED, Bisan; GUETENS, Gunter et al.Anticancer research. 2003, Vol 23, Num 5A, pp 4055-4059, issn 0250-7005, 5 p.Article

Melphalan availability in hypoxia-inducible factor-1α^+/+ and factor-1α^-/- tumors is independent of tumor vessel density and correlates with melphalan erythrocyte transportWILDIERS, Hans; GUETENS, Gunter; DE BOECK, Gert et al.International journal of cancer. 2002, Vol 99, Num 4, pp 514-519, issn 0020-7136Article

Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients : Analyis of EORTC-ISG-AGITG study 62005VERWEIJ, Jaap; CASALI, Paolo G; KOTASEK, Dusan et al.European journal of cancer (1990). 2007, Vol 43, Num 6, pp 974-978, issn 0959-8049, 5 p.Article

Proteomics in cancer research : Methods and application of array-based protein profiling technologiesHOEBEN, Ann; LANDUYT, Bart; BOTRUS, Gehan et al.Analytica chimica acta. 2006, Vol 564, Num 1, pp 19-33, issn 0003-2670, 15 p.Article

Randomized phase II/IIII trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma : The european organisation for research and treatment of cancer genito-urinary tract cancer group (EORTC 30951)AASS, Nina; DE MULDER, Pieter H. M; MICKISCH, Gerald H. J et al.Journal of clinical oncology. 2005, Vol 23, Num 18, pp 4172-4178, issn 0732-183X, 7 p.Article

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancerBAUR, Martina; VAN OOSTEROM, Allan T; DIERAS, Veronique et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 2, pp 125-135, issn 0171-5216, 11 p.Article

Association of enzyme and transporter genotypes with the pharmacoldnetics of imatinibGARDNER, Erin R; BURGER, Herman; FIGG, William D et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 2, pp 192-201, issn 0009-9236, 10 p.Article

Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours : an open-label belgian trialPRENEN, Hans; DUMEZ, Herlinde; DUCK, Lionel et al.Acta gastro-enterologica belgica (English ed.). 2006, Vol 69, Num 4, pp 367-371, issn 1784-3227, 5 p.Article

Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesHOEKSTRA, Ronald; DUMEZ, Herlinde; FIDLER, Isaiah J et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 6908-6915, issn 1078-0432, 8 p., 1Article

The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatmentDUMEZ, Herlinde; GUETENS, Gunther; DE BOECK, Gert et al.Clinical chemistry and laboratory medicine. 2004, Vol 42, Num 11, pp 1219-1227, issn 1434-6621, 9 p.Article

Immuno affinity purification combined with mass spectrometry detection for the monitoring of VEGF isoforms in patient tumor tissueLANDUYT, Bart; JANSEN, Jaap; WILDIERS, Hans et al.Journal of separation science. 2003, Vol 26, Num 6-7, pp 619-623, issn 1615-9306, 5 p.Article

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib : a randomised controlled trial. CommentaryJOENSUU, Heikki; DEMETRI, George D; MORGAN, Jeffrey A et al.Lancet (British edition). 2006, Vol 368, Num 9544, issn 0140-6736, 1303-1304,1329-1338 [12 p.]Article

Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCRSAAD ISMAIL, Mohamed; WYNENDAELE, Wim; VANDEKERCKHOVE, Philippe et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 196-201, issn 1078-0432, 6 p., 1Article

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma GroupVAN OOSTEROM, Allan T; JUDSON, Ian R; VERWEIJ, Jaap et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 5, pp S83-S87, issn 1359-6349Conference Paper

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours : a phase I studyVAN OOSTEROM, Allan T; JUDSON, Ian; SILBERMAN, Sandra et al.Lancet (British edition). 2001, Vol 358, Num 9291, pp 1421-1423, issn 0140-6736Article

Erythrocytes and the transfer of anticancer drugs and metabolites : a possible relationship with therapeutic outcomeDUMEZ, Herlinde; HIGHLEY, Martin; GUETENS, Gunther et al.Seminars in oncology. 2001, Vol 28, Num 2, pp 24-28, issn 0093-7754, SUP8Article

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)HEINRICH, Michael C; MCARTHUR, Grant A; DIRNHOFER, Stephan et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1195-1203, issn 0732-183X, 9 p.Article

Phase i pharmacokinetic, food effect, and pharmacogenetic study of oral Irinotecan given as semisolid matrix capsules in patients with solid tumorsSOEPENBERG, Otto; DUMEZ, Herlinde; LEFEBVRE, Patricia et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1504-1511, issn 1078-0432, 8 p.Article

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma: Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)FOSSA, Sophie D; MICKISCH, Gerald H. J; DE MULDER, Pieter H. M et al.Cancer. 2004, Vol 101, Num 3, pp 533-540, issn 0008-543X, 8 p.Article

Soft tissue sarcomas of adults: State of the translational scienceBORDEN, Ernest C; BAKER, Lurence H; O'SULLIVAN, Brian et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 1941-1956, issn 1078-0432, 16 p.Article

PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: A Phase I and pharmacokinetic studyGROEN, Harry J. M; DE VRIES, Elisabeth G. E; WYNENDAELE, Wim et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 3928-3933, issn 1078-0432Article